Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 3,228	$ 13,789
Marketable securities	15,958	19,537
Trade accounts receivable, net	5,934	6,368
Loan receivable from related party	0	2,001
Other current assets	4,489	2,316
Total current assets	29,609	44,011
Marketable securities	5,709	8,292
Property and equipment, net	2,922	2,875
Intangibles, net	41,833	6,611
Goodwill	6,412	1,114
Lease right of use assets	5,746	1,300
Other assets	1,268	673
Total assets	93,499	64,876
Current liabilities:
Accounts payable and other accrued liabilities	10,875	4,727
Deferred revenue	4,315	2,989
Total current liabilities	15,190	7,716
Long-term lease liabilities	6,267	1,028
Other long-term liabilities	519	752
Total liabilities	21,976	9,496
Commitments and contingencies (Note 14)
Shareholders’ equity:
Preferred stock (par value $0.001 per share, 2,500 authorized, 10 shares issued and outstanding at March 31, 2022 and December 31, 2021)	50	50
Common stock (par value $0.001 per share, 50,000 authorized, 17,687 and 16,940 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively)	18	17
Additional paid-in capital	296,364	261,324
Accumulated deficit	(223,792)	(206,011)
Accumulated other comprehensive loss	(1,117)	0
Total shareholders’ equity	71,523	55,380
Total liabilities and shareholders’ equity	$ 93,499	$ 64,876